Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

B. Hodsman, Anthony; C. Bauer, Douglas; W. Dempster, David; Dian, Larry; A. Hanley, David; T. Harris, Steven; L. Kendler, David; R. McClung, Michael; D. Miller, Paul; P. Olszynski, Wojciech; Orwoll, Eric; Kin Yuen, Chui

doi:10.1210/er.2004-0006

Public

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Published in Endocrine Reviews • Mar 15, 2005

Authors:

Anthony B. Hodsman

Douglas C. Bauer

David W. Dempster

Abstract

All therapies currently recommended for the management of osteoporosis act mainly to inhibit bone resorption and reduce bone remodeling. PTH and its analog, teriparatide [recombinant human PTH(1-34)], represent a new class of anabolic therapies for the treatment of severe osteoporosis, having the po...

Subject

Teriparatide

Medicine

Osteoporosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!